ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Palvella Therapeutics Inc

Palvella Therapeutics Inc (PVLA)

20,70
1,15
(5,88%)
Fermé 05 Mars 10:00PM
20,76
0,06
(0,29%)
Après les heures de négociation: 1:59AM

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

Dernier
20,70
Prix Achat
19,15
Prix Vente
24,32
Volume échangé
53 506
19,13 Fourchette du Jour 22,00
11,10 Plage de 52 semaines 21,71
Cap du marché
Clôture Veille
19,55
Ouverture
20,22
Dernière Transaction
1
@
19.67
Dernière heure de transaction
Volume financier
US$ 1 095 141
VWAP
20,4676
Volume moyen (3 m)
43 991
Actions en circulation
1 320 240
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-0,38
Bénéfice par action (BPA)
-55
Chiffre d'affairess
7,98M
Bénéfice net
-72,62M

À propos de Palvella Therapeutics Inc

Pieris Pharmaceuticals Inc is a clinical-stage biopharmaceutical company, which engages in the discovery and development of the Anticalin class of biotherapeutics. Anticalin proteins are engineered versions of lipocalins, human proteins that naturally bind, store and transport a wide spectrum of mol... Pieris Pharmaceuticals Inc is a clinical-stage biopharmaceutical company, which engages in the discovery and development of the Anticalin class of biotherapeutics. Anticalin proteins are engineered versions of lipocalins, human proteins that naturally bind, store and transport a wide spectrum of molecules. The company with the help of technology creates differentiated drugs such as PRS-080, PRS-060, PRS-343, and PRS-332 that can help patients suffering from cancer, severe asthma, anemia, and other medical conditions with a high unmet medical need. Geographically, all the operation of the firm functions through the region of the United States. Show more

Secteur
General Indl Mach & Eq, Nec
Industrie
Blank Checks
Site Web
Siège social
Wilmington, Delaware, USA
Fondé
2021
Palvella Therapeutics Inc est coté dans le secteur General Indl Mach & Eq de la NASDAQ avec le ticker PVLA. Le dernier cours de clôture d'Palvella Therapeutics était de US$19,55. Au cours de la dernière année, les actions de Palvella Therapeutics ont été négociées dans une fourchette de prix de US$ 11,10 à US$ 21,71.

Palvella Therapeutics compte actuellement 1 320 240 actions en circulation. La capitalisation boursière d'Palvella Therapeutics est de US$25,81 million. Palvella Therapeutics a un ratio cours/bénéfice (ratio PE) de -0.38.

PVLA Dernières nouvelles

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.713.5517758879419.9920.9918.542553019.30758682CS
47.7259.476117103212.9821.7112.80445184717.79041785CS
128.366.93548387112.421.7111.14399115.23809823CS
268.366.93548387112.421.7111.14399115.23809823CS
528.366.93548387112.421.7111.14399115.23809823CS
1568.366.93548387112.421.7111.14399115.23809823CS
2608.366.93548387112.421.7111.14399115.23809823CS

PVLA - Frequently Asked Questions (FAQ)

What is the current Palvella Therapeutics share price?
The current share price of Palvella Therapeutics is US$ 20,70
How many Palvella Therapeutics shares are in issue?
Palvella Therapeutics has 1 320 240 shares in issue
What is the market cap of Palvella Therapeutics?
The market capitalisation of Palvella Therapeutics is USD 25,81M
What is the 1 year trading range for Palvella Therapeutics share price?
Palvella Therapeutics has traded in the range of US$ 11,10 to US$ 21,71 during the past year
What is the PE ratio of Palvella Therapeutics?
The price to earnings ratio of Palvella Therapeutics is -0,38
What is the cash to sales ratio of Palvella Therapeutics?
The cash to sales ratio of Palvella Therapeutics is 3,44
What is the reporting currency for Palvella Therapeutics?
Palvella Therapeutics reports financial results in USD
What is the latest annual turnover for Palvella Therapeutics?
The latest annual turnover of Palvella Therapeutics is USD 7,98M
What is the latest annual profit for Palvella Therapeutics?
The latest annual profit of Palvella Therapeutics is USD -72,62M
What is the registered address of Palvella Therapeutics?
The registered address for Palvella Therapeutics is 108 W. 13TH STREET SUITE 100, WILMINGTON, DELAWARE, 19801
What is the Palvella Therapeutics website address?
The website address for Palvella Therapeutics is www.sarcos.com
Which industry sector does Palvella Therapeutics operate in?
Palvella Therapeutics operates in the BLANK CHECKS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
MASS908 Devices Inc
US$ 3,88
(95,96%)
124,48M
FRGTFreight Technologies Inc
US$ 1,5606
(51,51%)
77,46M
HOTHHoth Therapeutics Inc
US$ 1,23
(41,38%)
11,43M
JZXNJiuzi Holdings Inc
US$ 4,29
(41,12%)
98,71k
ATLNAtlantic International Corporation
US$ 4,61
(40,12%)
136,23k
AGHAureus Greenway Holdings Inc
US$ 0,7621
(-64,88%)
4,46M
NKGNNKGen Biotech Inc
US$ 0,1944
(-62,31%)
8,44M
TNYATenaya Therapeutics Inc
US$ 0,4206
(-55,58%)
25,91M
PSTVPlus Therapeutics Inc
US$ 0,302249
(-54,20%)
4,78M
PCLAPicoCELA Inc
US$ 1,56
(-50,16%)
1,13M
NVDANVIDIA Corporation
US$ 115,99
(1,69%)
398,59M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 11,52
(-9,08%)
192,73M
INTCIntel Corporation
US$ 21,33
(-6,20%)
152,18M
BTOGBit Origin Ltd
US$ 0,35
(9,61%)
135,4M
UOKAMDJM Ltd
US$ 0,179799
(19,87%)
131,96M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock